The c-erbB3/HER3 receptor in human cancer
Gullick, W.J.
Cancer Surveys 27: 339-349
1996
ISSN/ISBN: 0261-2429 PMID: 8909809 Document Number: 468025
c-erbB3 is a receptor for NDF/heregulin that can engage in heterodimerization with other type I receptor tyrosine kinases. Despite very limited kinase activity, it can stimulate responses in heterodimers not evoked by other family members. It is overexpressed frequently in several common solid tumours and thus represents a target for new forms of therapies.
Document emailed within 1 workday
Related Documents
Robertson, K.W.; Reeves, J.R.; Smith, G.; Keith, W.N.; Ozanne, B.W.; Cooke, T.G.; Stanton, P.D. 1996: Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer Cancer Research 56(16): 3823-3830Huynh, H.; Nguyen, T.Thanh.Tuyen.; Chan, E.; Tran, E. 2003: Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation International Journal of Oncology 23(3): 821-829
Aryandono, T.; Harijadi; Ghozali, A. 2000: Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 600-606
Liu, C.; Park, M.; Tsao, M.S. 1992: Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas Oncogene 7(1): 181-185
Bottini, A.; Berruti, A.; Bersiga, A.; Brunelli, A.; Brizzi, M.P.; Marco, B.D.; Cirillo, F.; Bolsi, G.; Bertoli, G.; Alquati, P.; Dogliotti, L. 1996: Effect of neoadjuvant chemotherapy on Ki67 labelling index, c-erbB-2 expression and steroid hormone receptor status in human breast tumours Anticancer Research 16(5b): 3105-3110
Wright, C.; Angus, B.; Nicholson, S.; Sainsbury, J.R.; Cairns, J.; Gullick, W.J.; Kelly, P.; Harris, A.L.; Horne, C.H. 1989: Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer Cancer Research 49(8): 2087-2090
Szöllösi, J.; Balázs, M.; Feuerstein, B.G.; Benz, C.C.; Waldman, F.M. 1995: ERBB-2 (HER2/neu) gene copy number, p185HER-2 overexpression, and intratumor heterogeneity in human breast cancer Cancer Research 55(22): 5400-5407
Wang, S.-l.; Li, Y.-x.; Song, Y.-w.; Wang, W.-h.; Jin, J.; Liu, Y.-p.; Liu, X.-f.; Yu, Z.-h. 2010: Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy Zhonghua Zhong Liu Za Zhi 32(7): 520-525
Mori, T.; Morimoto, T.; Komaki, K.; Monden, Y. 1989: The receptor status between in primary tumor and in its involved regional node referring to estrogen receptor and epidermal growth factor receptor in human breast cancer: preliminary report Nihon Geka Gakkai Zasshi 90(10): 1820
Sugano, K.; Kawai, T.; Ishii, M.; Koyama, H.; Kitajima, M.; Kasumi, F.; Demura, R.; Nakayama, T.; Okabe, H.; Mori, S. 1994: Clinical evaluation of serum ErbB-2 protein using enzyme immuno assay (ErbB-2 EIA [Nichirei]) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(8): 1255-1262
Kniazev, P.G.; Imianitov, E.N.; Chernitsa, O.I.; Nikiforova, I.F.; Babenko, V.I.; Bruderliaĭn, S.; Plutalo, O.V.; Kuz'min, A.I.; Kaboev, O.K.; Berlin, I.A. 1992: Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma Molekuliarnaia Biologiia 26(5): 1134-1147
King, C.R.; Borrello, I.; Porter, L.; Comoglio, P.; Schlessinger, J. 1989: Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock Oncogene 4(1): 13-18
Olapade-Olaopa, E.O.; Moscatello, D.K.; MacKay, E.H.; Sandhu, D.P.S.; Terry, T.R.; Wong, A.J.; Habib, F.K. 2004: Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer African Journal of Medicine and Medical Sciences 33(3): 245-253
Castles, C.G.; Fuqua, S.A.; Klotz, D.M.; Hill, S.M. 1993: Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line Cancer Research 53(24): 5934-5939
Horwitz, K.B.; McGuire, W.L. 1978: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor Journal of Biological Chemistry 253(7): 2223-2228
Imianitov, E.N.; Chernitsa, O.I.; Nikiforova, I.F.; Titov, K.V.; Khanson, K.P.; Kniazev, P.G. 1992: The search for amplification of the ERBB-2 oncogene in human tumors Voprosy Onkologii 38(6): 652-659
Chearskul, S.; Sinlarat, P.; Bhothisuwan, K.; Churintrapun, M.; Ornrhebroi, S.; Klinsala, N.; Sungkabunchoo, S. 2000: Serum c-erbB-2 protein in breast cancer patients Journal of the Medical Association of Thailand 83(8): 886-893
Maurer-Gebhard, M.; Schmidt, M.; Azemar, M.; Altenschmidt, U.; Stöcklin, E.; Wels, W.; Groner, B. 1998: Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells Cancer Research 58(12): 2661-2666
Craven, J.M.; Pavelic, Z.P.; Stambrook, P.J.; Pavelic, L.; Gapany, M.; Kelley, D.J.; Gapany, S.; Gluckman, J.L. 1992: Expression of c-erbB-2 gene in human head and neck carcinoma Anticancer Research 12(6b): 2273-2276
Pierce, J.H.; Arnstein, P.; DiMarco, E.; Artrip, J.; Kraus, M.H.; Lonardo, F.; Di Fiore, P.P.; Aaronson, S.A. 1991: Oncogenic potential of erbB-2 in human mammary epithelial cells Oncogene 6(7): 1189-1194